Athens Medical C.S.A. Statistics

Total Valuation

Athens Medical C.S.A. has a market cap or net worth of EUR 130.10 million. The enterprise value is 256.57 million.

Market Cap	130.10M
Enterprise Value	256.57M

Important Dates

The next estimated earnings date is Friday, May 2, 2025.

Earnings Date	May 2, 2025
Ex-Dividend Date	Jul 22, 2024

Share Statistics

Athens Medical C.S.A. has 86.74 million shares outstanding. The number of shares has decreased by -0.06% in one year.

Current Share Class	n/a
Shares Outstanding	86.74M
Shares Change (YoY)	-0.06%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.26%
Float	n/a

Valuation Ratios

The trailing PE ratio is 14.35.

PE Ratio	14.35
Forward PE	n/a
PS Ratio	0.52
PB Ratio	1.20
P/TBV Ratio	1.23
P/FCF Ratio	34.43
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.78, with an EV/FCF ratio of 67.89.

EV / Earnings	31.75
EV / Sales	1.03
EV / EBITDA	6.78
EV / EBIT	10.60
EV / FCF	67.89

Financial Position

The company has a current ratio of 0.98, with a Debt / Equity ratio of 1.46.

Current Ratio	0.98
Quick Ratio	0.95
Debt / Equity	1.46
Debt / EBITDA	4.17
Debt / FCF	41.94
Interest Coverage	2.38

Financial Efficiency

Return on equity (ROE) is 7.70% and return on invested capital (ROIC) is 5.61%.

Return on Equity (ROE)	7.70%
Return on Assets (ROA)	3.22%
Return on Capital (ROIC)	5.61%
Revenue Per Employee	79,989
Profits Per Employee	2,502
Employee Count	3,230
Asset Turnover	0.58
Inventory Turnover	27.51

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.21% in the last 52 weeks. The beta is 1.14, so Athens Medical C.S.A.'s price volatility has been higher than the market average.

Beta (5Y)	1.14
52-Week Price Change	-20.21%
50-Day Moving Average	1.51
200-Day Moving Average	1.60
Relative Strength Index (RSI)	44.73
Average Volume (20 Days)	2,335

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Athens Medical C.S.A. had revenue of EUR 258.36 million and earned 8.08 million in profits. Earnings per share was 0.09.

Revenue	258.36M
Gross Profit	66.56M
Operating Income	23.10M
Pretax Income	13.70M
Net Income	8.08M
EBITDA	38.03M
EBIT	23.10M
Earnings Per Share (EPS)	0.09

Full Income Statement

Balance Sheet

The company has 21.96 million in cash and 158.51 million in debt, giving a net cash position of -136.55 million or -1.57 per share.

Cash & Cash Equivalents	21.96M
Total Debt	158.51M
Net Cash	-136.55M
Net Cash Per Share	-1.57
Equity (Book Value)	108.77M
Book Value Per Share	1.25
Working Capital	-3.30M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 26.13 million and capital expenditures -22.35 million, giving a free cash flow of 3.78 million.

Operating Cash Flow	26.13M
Capital Expenditures	-22.35M
Free Cash Flow	3.78M
FCF Per Share	0.04

Full Cash Flow Statement

Margins

Gross margin is 25.76%, with operating and profit margins of 8.94% and 3.13%.

Gross Margin	25.76%
Operating Margin	8.94%
Pretax Margin	5.30%
Profit Margin	3.13%
EBITDA Margin	14.72%
EBIT Margin	8.94%
FCF Margin	1.46%

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 1.33%.

Dividend Per Share	0.02
Dividend Yield	1.33%
Dividend Growth (YoY)	-33.33%
Years of Dividend Growth	n/a
Payout Ratio	0.75%
Buyback Yield	0.06%
Shareholder Yield	1.39%
Earnings Yield	6.21%
FCF Yield	2.90%

Dividend Details

Stock Splits

The last stock split was on February 8, 2000. It was a forward split with a ratio of 2.

Last Split Date	Feb 8, 2000
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a